/IQAIF

IQAIF Stock - Imaging Biometrics Ltd.

Q: What is the analyst price target for IQAIF?

Analyst price target information is not currently available for IQAIF.

Q: What is IQAIF's market cap?

Market capitalization information is not currently available for IQAIF.

Healthcare|Medical - Healthcare Information Services|OTC

$0.02+0.00%

+$0.00 (+0.00%) • Oct 22

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.02

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IQAIF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta2.59

52W High$0.02

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$750,105	$609,390	$535,886	$521,069	$255,314
Gross Profit	$742,339	$597,754	$534,104	$504,022	$246,767
Gross Margin	99.0%	98.1%	99.7%	96.7%	96.7%
Operating Income	$-327,513	$-406,324	$-500,891	$-490,348	$-685,722
Net Income	$-327,103	$-623,816	$-522,311	$-511,768	$-749,346
Net Margin	-43.6%	-102.4%	-97.5%	-98.2%	-293.5%
EPS	$-0.00	$-0.00	$-0.00	$-0.00	$-0.01

Company Overview

IQ-AI Limited focuses on advancing healthcare by developing and commercializing state-of-the-art medical software solutions and services. In March 2018, IQ-AI Ltd acquired Imaging Biometrics, LLC (IB), a Wisconsin USA-based medical imaging software company. In addition to providing regulatory consulting services, IB supplies medical technology solutions and has a strong neuroimaging product portfolio. IB's analytical solutions enable clinicians to better diagnose and treat disease with greater confidence. IB is the second acquisition made by IQ-AI in the medical imaging space after acquiring Stone Checker Software Ltd in 2017.

Visit Website

Frequently Asked Questions about IQAIF

What is IQAIF's current stock price?

Imaging Biometrics Ltd. (IQAIF) is currently trading at $0.02 per share. The stock has moved +0.00% today.

What is the analyst price target for IQAIF?

No analyst price targets are currently available for this stock.

What sector is Imaging Biometrics Ltd. in?

Imaging Biometrics Ltd. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.

What is IQAIF's market cap?

Imaging Biometrics Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.

Does IQAIF pay dividends?

No, Imaging Biometrics Ltd. does not currently pay a dividend to shareholders.